Skip to main content

New story in Health from Time: WNBA’s Elena Delle Donne Is ‘Hurt’ League Denied Her a Medical Waiver Despite Taking 64 Pills a Day



(NEW YORK) — WNBA MVP Elena Delle Donne was shocked and hurt when her request to be medically excused for the season was denied by an independent medical panel.

Having battled Lyme disease for more than a decade and now taking 64 pills a day, she thought she was definitely going to be considered high-risk to get severe illness if she contracted the coronavirus.

The panel of independent doctors the league and union agreed upon to make that decision thought otherwise, ruling Monday that she was not “high risk, and should be permitted to play in the bubble.”

The disease is not included on the Centers for Disease Control and Prevention’s list of underlying conditions that could put someone at an increased risk for severe illness from COVID-19.

The Washington Mystics star wrote in The Players’ Tribune on Wednesday about her disappointment with the panel’s ruling and the decision to “risk my life … or forfeit my paycheck.”

“It hurts a lot. And maybe being hurt just makes me naive,” Delle Donne wrote. “And I know that, as athletes, we’re not really supposed to talk about our feelings. But feelings are pretty much all I have left right now. I don’t have NBA player money. I don’t have the desire to go to war with the league on this. And I can’t appeal.”

Delle Donne, who just re-signed with Washington in February and would make $215,000 this year, said she’s still deciding what she’s going to do.

She’s on Washington’s roster and is currently getting paid by the Mystics. She had back surgery in late January to address the three herniated disks she suffered in the playoffs last year. The season begins on July 25 and according to her agent, the team wants Delle Donne to come to Florida in August once she’s ready to play.

Had Delle Donne been medically excused, she would have earned her entire salary for the season. Now, if she chooses not to play, the defending WNBA champion Mystics wouldn’t have to pay her.

The 30-year-old forward acknowledges in her open letter that she could have done more over the past six years to help take a more public role in the fight against Lyme disease. She was the first national ambassador to help promote awareness of the tick-borne disease, joining on in 2014.

She is coming off a historic season where she helped lead Washington to its first WNBA title. She shot over 50% from the field, 40% from behind the 3-point arc and over 90% from the foul line last season to become the first player in league history to do so.

Delle Donne’s new teammate Tina Charles also was waiting for a decision from the medical panel. If both players miss the season, the Mystics would be down to 10 players on the roster.

“As with all of our players, we have and will support Elena throughout this process. The health and well-being of our players is of the utmost importance,” Mystics coach and general manager Mike Thibault said.

Charles and Delle Donne did not travel with the team to Bradenton, Florida. The WNBA is using IMG Academy as a single site for its season which will begin on July 25.

There are a handful of players who are waiting to have their cases heard by the three-person panel. Phoenix forward Jessica Breland, who missed a year while at North Carolina to be treated for Hodgkin’s lymphoma, was deemed high-risk and was medically excused, the Mercury said.

Popular posts from this blog

New story in Health from Time: Here’s How Quickly Coronavirus Is Spreading in Your State

The novel coronavirus pandemic is a global crisis, a national emergency and a local nightmare. But while a great deal of the focus in the U.S. has been on the federal government’s response, widely criticized as slow and halting , the picture on the ground remains very different in different parts of the country. A TIME analysis of the per capita spread of the epidemic in all 50 states and Washington, D.C. found considerable range in the rate of contagion, and, in some parts of the country, a significant disparity compared to the national figure. The U.S., unlike nations such as South Korea and now Italy , has yet to show signs of bringing the runaway spread of the virus under control. However, while no single state is yet showing strong signs of bending the curve , some are faring much worse than others. The following graphic plots the rise in the total confirmed cases of COVID-19 per 100,000 residents in each state, plotted by the day that each state reported its first case.

New story in Health from Time: We Need to Take Care of the Growing Number of Long-term COVID-19 Patients

On July 7, 2020, the Boston Red Sox pitcher Eduardo Rodriguez tested positive for the new coronavirus. He was scheduled to start Opening Day for the Sox, but the virus had other plans— damaging Rodriguez’s heart and causing a condition called myocarditis (inflammation of the heart muscle). Now the previously fit 27-year old ace left-hander must sit out the 2020 season to recover. Rodriguez is not alone in having heart damage from SARS-CoV-2, the virus that causes COVID-19. In a new study done in Germany, researchers studied the hearts of 100 patients who had recently recovered from COVID-19. The findings were alarming: 78 patients had heart abnormalities, as shown by a special kind of imaging test that shows the heart’s structure (a cardiac MRI), and 60 had myocarditis. These patients were mostly young and previously healthy . Several had just returned from ski trips. While other studies have shown a lower rate of heart problems—for example, a study of 416 patients hosp

New story in Health from Time: What We Don’t Know About COVID-19 Can Hurt Us

Countries around the world have introduced stringent control measures to stop COVID-19 outbreaks growing, but now many find themselves facing the same situation again. From Melbourne to Miami, the relaxation of measures had led to increasing flare-ups, which in some places has already meant reclosing schools, businesses or travel routes. Within the U.S. and among different countries , places with wildly varying public-health policies have experienced wildly diverse outcomes. Most ominously, infections are rising rapidly in many places where they once were falling. So how do countries avoid an indefinite, unsustainable, cycle of opening and closing society? What is needed to prevent a future of strict social distancing and closed borders? To escape this limbo, we need to know more about each step in the chain of infection: why some people are more susceptible or have more symptoms, how our interactions and surroundings influence risk, and how we can curb the impact of the re